What is the CGM Market Size?
According to 6Wresearch internal data and global sources, the CGM market was valued at approximately USD 4.60 billion in 2024 and is projected to reach USD 7.51 billion by 2031, exhibiting a CAGR of 7.2%.
Growth is driven by the rising prevalence of diabetes, growing use of CGM in non-insulin reliant populations, sports and wellness applications, and accelerating technological advancements.
Key Growth Drivers
- Rising rate of diabetes in the world and obesity prevalence
- The increasing popularity of real-time monitoring glucose insulin input in place of the older ones
- Innovation in non-invasive sensors and Bluetooth connecting technology
- Homecare adoption and insurance reimbursement expansion
- Applications in sports, healthcare as well as fitness markets, on non-diabetics
- People are increasingly becoming educated about metabolic wellness and prevention
CGM Market Trends
CGM Market is expected to evolve with trends such as wider use of over-the-counter sensors for metabolic tracking, greater integration with smartphones and fitness devices, and emerging AI-powered analytics for predictive glucose insights. Sensor segment will continue dominating, supported by enhanced accuracy and longevity. Geographic expansion in Asia-Pacific and Latin America will accelerate due to improving healthcare infrastructure and increased awareness. Additionally, new competition from FDA-cleared OTC products targeting wellness users is reshaping adoption patterns.
Major Companies
- Dexcom, Inc.
- Abbott Laboratories (FreeStyle Libre, Lingo, Libre Rio)
- Medtronic plc
- Senseonics Holdings, Inc.
- Roche (Accu-Chek CGM)
Frequently Asked Questions About the Market Study (FAQs):
The market was valued at USD 4.60 billion in 2023 and is projected to grow at a CAGR of 7.2% through 2031, reaching approximately USD 7.51 billion.
North America holds the largest share (around 39%), while Asia-Pacific is the fastest-growing region.
Sensor component dominates, accounting for over 40% of revenue due to frequency of use and accuracy advancements.
High device cost, regulatory hurdles for non-diabetic use, and cybersecurity concerns for connected CGM systems.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com